Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$6.9 - $9.59 $11,012 - $15,305
-1,596 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$8.58 - $10.21 $720 - $857
-84 Reduced 5.0%
1,596 $15,000
Q3 2020

Nov 13, 2020

SELL
$12.07 - $15.31 $8,135 - $10,318
-674 Reduced 28.63%
1,680 $20,000
Q2 2020

Aug 14, 2020

BUY
$10.25 - $16.54 $92 - $148
9 Added 0.38%
2,354 $32,000
Q1 2020

May 14, 2020

SELL
$7.91 - $16.96 $4,026 - $8,632
-509 Reduced 17.83%
2,345 $24,000
Q4 2019

Feb 13, 2020

BUY
$13.48 - $15.86 $7,144 - $8,405
530 Added 22.81%
2,854 $45,000
Q2 2019

Aug 14, 2019

BUY
$10.68 - $14.55 $24,820 - $33,814
2,324 New
2,324 $27,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $220M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.